PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-90.38%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
28.82%
Positive gross profit growth while JHX is negative. John Neff would see a clear operational edge over the competitor.
38.02%
EBIT growth below 50% of JHX's 386.17%. Michael Burry would suspect deeper competitive or cost structure issues.
38.02%
Operating income growth under 50% of JHX's 123.19%. Michael Burry would be concerned about deeper cost or sales issues.
166.26%
Net income growth above 1.5x JHX's 43.58%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
156.25%
EPS growth above 1.5x JHX's 50.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
146.67%
Diluted EPS growth above 1.5x JHX's 51.06%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.70%
Slight or no buybacks while JHX is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
12.70%
Diluted share count expanding well above JHX's 0.12%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-80.09%
Negative 10Y revenue/share CAGR while JHX stands at 117.83%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-80.65%
Negative 5Y CAGR while JHX stands at 48.10%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-87.38%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
192.86%
Below 50% of JHX's 586.41%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
57.69%
Positive short-term CAGR while JHX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.